Select Page

What Oxygen Level Should I Use for My Cells In Vitro?

Well, it depends.

Learning how to determine oxygen levels for your in vitro culture is important to producing relevant results.

Are you looking for physiological relevance or comparison with cells cultured in a standard room-air incubator?

First, you should know that there is nothing normal or “normoxic” about room air oxygen for cells that normally reside inside the body.In vivo, as soon as air enters the body, it mixes with CO2 being expired and the percentage of oxygen decreases.

 

In vitro, while an incubation chamber can certainly be controlled to 20.8% oxygen (generally accepted to be room air), this is supraphysiologic.

If you want to assay your cells in comparison with a standard CO2-controlled incubator, you also should not use 20.8% oxygen. We’ve measured the oxygen in those incubators and it is lower, 17.2 +/- 0.3% (n=4 incubators in three different institutions) when it first equilibrated. This value slowly drifted to 19% if the door was kept closed for three days.

Why are incubator oxygen levels lower than room air?

The CO2 is set to 5% and room air is usually less than 1% CO2. Every time you open the inner door, CO2 is infused to replace the CO2 lost to the room and it displaces oxygen. Also, high humidity means that water vapor necessarily takes up gas volume in your incubator; up to 8%. See relevant data in a previous post.

I want physiologically-relevant oxygen for my cells. How much should I use?

Oxygen levels in the body vary widely depending upon the physiologic or pathophysiologic context. Venous blood is generally accepted to contain 5% oxygen. Some tissues, like bone marrow or fetal tissues, can normally experience much lower oxygen levels. Tissues with little vasculature, like cartilage or the interior of large solid tumors, can be close to anoxic (0%).

We strongly recommend that you refer to scientific literature related to your specific cell or tissue model to determine the best oxygen level for your cell culture.

These reviews can help you get started:

1. Jež M, Rožman P, Ivanović Z, Bas T. Concise Review: The Role of Oxygen in Hematopoietic Stem Cell Physiology. Journal of cellular physiology. 2015;230(9):1999-2005.

2. Carreau A, Hafny‐Rahbi BE, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. Journal of cellular and molecular medicine. 2011;15(6):1239-53.

3. Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell stem cell. 2010;7(2):150-61.

 


Recent Articles

Cytocentric Visionaries: Dr. David Gozal, MD – Part Two

Cytocentric Visionaries: Dr. David Gozal, MD – Part Two

Cytocentric Visionaries: Dr. David Gozal, MD Part 2: COVID-19 Research, Prone Positioning, and Chronoadequacy Alicia Henn, PhD MBA, Chief Scientific Officer, BioSpherix David Gozal, MD, MBA, PhD (Hon) is the Marie M. and Harry L. Smith Endowed Chair and Chairperson of...

Cytocentric Visionaries: Dr. David Gozal, MD – Part One

Cytocentric Visionaries: Dr. David Gozal, MD – Part One

Cytocentric Visionaries: Dr. David Gozal, MD Part 1: COVID-19, ACE2, and the Circadian Clock Alicia Henn, PhD MBA, Chief Scientific Officer, BioSpherix David Gozal, MD, MBA, PhD (Hon) is the Marie M. and Harry L. Smith Endowed Chair and Chairperson of the Department...

Cytocentric Visionaries: David Lawrence

Cytocentric Visionaries: David Lawrence

Cytocentric Visionaries: Dr. David Lawrence, University at Albany Inflammation and Oxidative Stress: Cell Conditions Matter, Even for CAR-T Dr. David A Lawrence is Professor and Chair of Environmental Health Sciences, at the School of Public Health and the University...

About The Author

Alicia D Henn, PhD, MBA

Alicia D Henn, PhD, MBA

Chief Scientific Officer of BioSpherix, Ltd

 

 

Alicia Henn has been the Chief Scientific Officer of BioSpherix, Ltd since 2013. Previously, she was a researcher at the Center for Biodefense Immune Modeling in Rochester, NY. Alicia obtained her PhD in molecular pharmacology and cancer therapeutics from Roswell Park Cancer Institute in Buffalo, NY and her MBA from the Simon School at University of Rochester in Rochester, NY.

ahenn@biospherix.com

 

 

If you would like to be featured in our Cytocentric Visionary Seriescontact us. We would love to hear about your work.